Results 21 to 30 of about 29,949 (204)
Comparative study: Post-operative variables (branded enoxaparin vs biosimilar enoxaparin groups).
, 2023 Comparative study: Post-operative variables (branded enoxaparin vs biosimilar enoxaparin groups).
Chadli Dziri (14048856) +7 more
core +1 more source
SAGE Open Medical Case Reports, 2022 Enoxaparin is a low molecular weight heparin that is principally prescribed for the treatment and prevention of thromboembolic disorders. In clinical practice, the abdominal site for subcutaneous enoxaparin administration is most preferable because of ...
Vichapat Tharanon +1 more
doaj +1 more source
, 2023 Comparative study: Pre and intraoperative variables (branded enoxaparin vs biosimilar enoxaparin groups).
Chadli Dziri (14048856) +7 more
core +1 more source
Dosis Efektif Enoxaparin dalam Mencegah Terjadinya Trombosis pada Anastomosis Arteri Femoralis Tikus
JBN (Jurnal Bedah Nasional), 2017 Tujuan: untuk mengetahui dosis efektif enoxaparin dalam mencegah terjadinya trombosis pada anastomosis mikrovaskular. Metode: penelitian ini bersifat eksperimental dengan rancangan the randomized post test only control group design.
I Made Suka Adnyana +1 more
doaj +1 more source
Dose-dependent neuroprotective effect of enoxaparin on cold-induced traumatic brain injury
Neural Regeneration Research, 2017 Recent evidence exists that enoxaparin can reduce brain injury because of its anticoagulant activity. To investigate the potential therapeutic effect of enoxaparin on cold-induced traumatic brain injury, at 20 minutes after modeling, male BALB/c mouse ...
Ilknur Keskin +5 more
doaj +1 more source
Enoxaparin-induced reactive thrombocytosis: a case report
Thrombosis Journal, 2021 Background Enoxaparin is an anticoagulant that falls in the class of medications called low molecular weight heparins (LMWHs), and is used to prevent or treat patients with deep vein thrombosis (DVT) and pulmonary embolism.
Tao Xiang, Ming Cheng
doaj +1 more source
A complication of enoxaparin injection [PDF]
Cleveland Clinic Journal of Medicine, 2019 Computed tomography revealed a hematoma measuring 15 by 15 cm compressing the bladder and causing hydronephrosis.
Ahmad Muneer, Sharayah +3 more
openaire +2 more sources
Enoxaparin-induced hepatotoxicity: clinical cases and literature review [PDF]
, 2021 Low molecular weight heparins, in particular enoxaparin, have a wide range of applications, including prevention and treatment of deep vein thrombosis.
A. D. Аkhmedov +5 more
core +1 more source
Enoxaparin-induced hepatotoxicity: an under-recognised complication of enoxaparin therapy [PDF]
BMJ Case Reports, 2016 Low-molecular-weight heparins including enoxaparin are commonly used for anticoagulation as prophylaxis and treatment for deep vein thrombosis (DVT). Prescribers of enoxaparin monitor for common side effects, such as bleeding and thrombocytopenia, but hepatotoxicity, a less common and under-reported adverse effect, may be overlooked.
Katie Ann, Pivarnik +3 more
openaire +2 more sources
Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
Clinical Medicine Insights: Blood Disorders, 2019 Background: The appropriate dose of enoxaparin for venous thromboembolism (VTE) prophylaxis in low body weight patients is unknown. Objective: The aim of this study is to evaluate the impact of enoxaparin dosing on major and minor bleeding events in low ...
Daniel Dybdahl +4 more
doaj +1 more source